You are here
Articles
Posted on Monday, September 8, 2008 - 1:48pm
GVHD reversed by extracorporeal photopheresis-treated cells.
Posted on Thursday, September 4, 2008 - 6:06pm
New RCF report reveals striking postcode lottery in the chances of having an exceptional request for cancer treatment approved
Monday, August 11, 2008
Rarer Cancers Forum carried out an audit of the...
Posted on Tuesday, August 26, 2008 - 2:21pm
This webcast is an excellent backgrounder and will explain about the monitoring tests you should expect to have.
Posted on Monday, August 18, 2008 - 1:07pm
Press Release:
Leukemia Patient Groups call for improved access to cancer treatment
Baveno (Italy) 18 August 2008 · More than 50 organisations supporting patients with chronic myeloid leukaemia have...
Posted on Monday, August 11, 2008 - 12:38pm
John Carvel,
social affairs editor The Guardian, 11/08/08
A postcode lottery in cancer care was revealed yesterday in returns under the Freedom of Information Act showing where in England patients are most likely to be...
Posted on Friday, August 1, 2008 - 3:00pm
Hosted by Dr Ian Gibson MP and the Rarer Cancers Forum
Friday, July 25, 2008
Report on the Parliamentary Summit now available on the Rarer Cancer Forum website
....here
Posted on Friday, August 1, 2008 - 2:14pm
YOUR PATIENT'S RIGHT TO TREATMENT,
written by Peter Telford
Your Patient's Right to Treatment: Applying for NHS Exceptional Funding for Treatment
This 32-page booklet was written by a barrister, Peter...
Posted on Monday, July 7, 2008 - 2:44pm
How complete is “complete” molecular response in imatinib-treated chronic myeloid leukemia?
Posted on Monday, May 26, 2008 - 12:26pm
PETITION FOR BETTER AWARENESS ABOUT BONE MARROW DONATION
ADRIAN Sudbury is a 26-year-old journalist who has battled two forms of leukaemia for the past 18 months. His treatment included a bone marrow transplant. Sadly...
Posted on Friday, May 23, 2008 - 2:08pm
Britain's health service is spending half as much on cancer drugs as some other European countries
April 2008
Speaking at the European Breast Cancer Conference in Berlin, Professor Mike Richards, the national cancer...
Posted on Monday, May 19, 2008 - 12:31pm
Brian Druker's original research into developing a way of blocking the protein (BCR/ABL) that drives CML, culminated in the development of a Tyrosine Kinase Inhibitor... namely Glivec/imatinib.
Posted on Sunday, April 27, 2008 - 7:12pm
Medscape Hematology-Oncology
More: American Society of Hematology (ASH) 49th Annual Meeting and ExpositionNew Techniques Enabling a Greater Understanding of the Science and Biology of Leukemia:
An Expert...
Posted on Friday, April 11, 2008 - 3:50pm
EUTOS.
Posted on Thursday, March 27, 2008 - 11:25am
New Research Gives Additional Therapeutic Tools For Even More Effective And Longer Control Of Chronic Myeloid Leukemia
Main Category: Lymphoma / Leukemia
Article Date: 25 Mar 2008
Oregon Health & Science University...
Posted on Wednesday, February 27, 2008 - 10:48am
Update on the situation regarding NICE approval of dasatinib (Sprycel) and nilotinib (Tasigna).
- ‹ previous
- 31 of 33
- next ›